Literature DB >> 15798789

Autistic-like findings associated with a urea cycle disorder in a 4-year-old girl.

Işik Görker1, Umran Tüzün.   

Abstract

A 4-year-old girl presented at our clinic with autistic-like symptoms, aggressivity and occasional hyperactivity. She had no history of neurologic or physical symptoms. Her condition was diagnosed as pervasive developmental disorder not otherwise specified, according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV). She received pharmacologic (thioridazine), educational and speech therapy. During this process, a urea cycle disorder was also identified, namely, ornithine transcarbamylase deficiency and arginase deficiency, because of the high level of ammonia in the patient's bloodstream, the high level of organic acids in the 24-hour urine collection and the constant presence of slow multifocal epileptic discharges on the electroencephalograms. The patient's protein intake was restricted, and she was treated with sodium benzoate and arginine. After 1 year of treatment, the autistic-like findings and hyperactivity were no longer apparent.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15798789      PMCID: PMC551172     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  7 in total

1.  Retrospective survey of urea cycle disorders: Part 2. Neurological outcome in forty-nine Japanese patients with urea cycle enzymopathies.

Authors:  N Nagata; I Matsuda; T Matsuura; K Oyanagi; K Tada; K Narisawa; T Kitagawa; T Sakiyama; F Yamashita; M Yoshino
Journal:  Am J Med Genet       Date:  1991-09-15

2.  Arginase deficiency.

Authors:  R Christopher; V Rajivnath; K T Shetty
Journal:  Indian J Pediatr       Date:  1997 Mar-Apr       Impact factor: 1.967

3.  Recurrent episodes of bizarre behavior in a boy with ornithine transcarbamylase deficiency: diagnostic failure of protein loading and allopurinol challenge tests.

Authors:  M Spada; O Guardamagna; D Rabier; S B van der Meer; P Parvy; J Bardet; A Ponzone; J M Saudubray
Journal:  J Pediatr       Date:  1994-08       Impact factor: 4.406

Review 4.  Metabolic disorders presenting with behavioral symptoms in the school-aged child.

Authors:  R R Trifiletti; A M Packard
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  1999-10

Review 5.  Biochemical aspects in autism spectrum disorders: updating the opioid-excess theory and presenting new opportunities for biomedical intervention.

Authors:  Paul Shattock; Paul Whiteley
Journal:  Expert Opin Ther Targets       Date:  2002-04       Impact factor: 6.902

Review 6.  The neurobiology and genetics of infantile autism.

Authors:  L J Lotspeich; R D Ciaranello
Journal:  Int Rev Neurobiol       Date:  1993       Impact factor: 3.230

7.  Risk of serious illness in heterozygotes for ornithine transcarbamylase deficiency.

Authors:  M L Batshaw; M Msall; A L Beaudet; J Trojak
Journal:  J Pediatr       Date:  1986-02       Impact factor: 4.406

  7 in total
  17 in total

Review 1.  Medical comorbidities in autism: challenges to diagnosis and treatment.

Authors:  Margaret L Bauman
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

2.  Autism spectrum disorder in a child with propionic acidemia.

Authors:  M Al-Owain; N Kaya; H Al-Shamrani; A Al-Bakheet; A Qari; S Al-Muaigl; M Ghaziuddin
Journal:  JIMD Rep       Date:  2012-03-31

3.  [Ornithine transcarbamylase deficiency in adolescence and adulthood: first manifestation with life-threatening decompensation].

Authors:  M Bürle; H Mende; U Plum; M Bluthardt; M Walka; G Geldner
Journal:  Anaesthesist       Date:  2009-06       Impact factor: 1.041

Review 4.  Suggested guidelines for the diagnosis and management of urea cycle disorders.

Authors:  Johannes Häberle; Nathalie Boddaert; Alberto Burlina; Anupam Chakrapani; Marjorie Dixon; Martina Huemer; Daniela Karall; Diego Martinelli; Pablo Sanjurjo Crespo; René Santer; Aude Servais; Vassili Valayannopoulos; Martin Lindner; Vicente Rubio; Carlo Dionisi-Vici
Journal:  Orphanet J Rare Dis       Date:  2012-05-29       Impact factor: 4.123

5.  Should metabolic diseases be systematically screened in nonsyndromic autism spectrum disorders?

Authors:  Manuel Schiff; Jean-François Benoist; Sofiane Aïssaoui; Odile Boespflug-Tanguy; Odile Boepsflug-Tanguy; Marie-Christine Mouren; Hélène Ogier de Baulny; Richard Delorme
Journal:  PLoS One       Date:  2011-07-07       Impact factor: 3.240

Review 6.  Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis.

Authors:  D A Rossignol; R E Frye
Journal:  Mol Psychiatry       Date:  2011-01-25       Impact factor: 15.992

7.  Glyphosate, pathways to modern diseases III: Manganese, neurological diseases, and associated pathologies.

Authors:  Anthony Samsel; Stephanie Seneff
Journal:  Surg Neurol Int       Date:  2015-03-24

Review 8.  A review of traditional and novel treatments for seizures in autism spectrum disorder: findings from a systematic review and expert panel.

Authors:  Richard E Frye; Daniel Rossignol; Manuel F Casanova; Gregory L Brown; Victoria Martin; Stephen Edelson; Robert Coben; Jeffrey Lewine; John C Slattery; Chrystal Lau; Paul Hardy; S Hossein Fatemi; Timothy D Folsom; Derrick Macfabe; James B Adams
Journal:  Front Public Health       Date:  2013-09-13

9.  Psychiatric adult-onset of urea cycle disorders: A case-series.

Authors:  Adrien Bigot; Paul Brunault; Christian Lavigne; François Feillet; Sylvie Odent; Elsa Kaphan; Christel Thauvin; Vanessa Leguy; Pierre Broué; Michel C Tchan; François Maillot
Journal:  Mol Genet Metab Rep       Date:  2017-07-06

Review 10.  Profiles of urine and blood metabolomics in autism spectrum disorders.

Authors:  Narueporn Likhitweerawong; Chanisa Thonusin; Nonglak Boonchooduang; Orawan Louthrenoo; Intawat Nookaew; Nipon Chattipakorn; Siriporn C Chattipakorn
Journal:  Metab Brain Dis       Date:  2021-08-02       Impact factor: 3.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.